Sign in
Theodore Wahl

Theodore Wahl

President & Chief Executive Officer at HEALTHCARE SERVICES GROUPHEALTHCARE SERVICES GROUP
CEO
Executive
Board

About Theodore Wahl

Theodore “Ted” Wahl, age 51, is President & CEO of Healthcare Services Group, Inc. (HCSG) and a director since 2011; he became CEO in May 2015 after joining HCSG in 2004 and rising through COO, VP Finance, and field leadership roles; earlier he was a Senior Manager in EY’s Transaction Advisory Group . Under his tenure, HCSG’s pay-versus-performance disclosure shows cumulative total shareholder return (TSR) of $54 on an initial $100 over the 2020–2024 window versus $164 for the selected peer group, while 2024 also featured year-over-year increases in revenues and net income and returns of ROA 4.9%, ROE 7.9%, ROIC 9.7% . Say-on-pay support has been consistently strong (≈91% in 2024; 93% in 2023), and the CEO’s base salary has been unchanged since 2016, with performance pay tied primarily to income before income taxes (IBIT) and long-term equity (options, RSUs, PSUs) .

Past Roles

OrganizationRoleYearsStrategic / Operating Impact
Healthcare Services Group, Inc.President & Chief Executive OfficerMay 2015–presentLed recovery and growth pivot; maintained CEO comp structure tied to IBIT and multi-year equity; 2024 YOY revenue and net income increases; ROA 4.9%, ROE 7.9%, ROIC 9.7% .
Healthcare Services Group, Inc.President & Chief Operating Officer; EVP & COO; VP Finance; Regional Manager; Regional Sales Director; District & Facility Manager2004–2015Field-to-C-suite progression, operational and financial accountability; compensation design emphasizes alignment via options/RSUs/PSUs .
Ernst & Young (EY)Senior Manager, Transaction Advisory Servicespre-2004Transaction diligence background; adds financial rigor to operating role .

External Roles

OrganizationRoleYearsStrategic Impact
No other public company directorships disclosed for Wahl; primary external prior role at EY (transactions) .

Fixed Compensation

Metric202220232024
Base Salary ($)1,005,108 1,005,108 1,005,108; unchanged since 2016
Other Compensation ($)45,709 47,207 49,887
CEO Pay Ratio143:1 (FY23) 145:1 (FY24)

Perquisites include health, dental, optical (employee co-pay), life/disability insurance, and a company fleet vehicle .

Performance Compensation

Annual Incentive (Short-Term)

  • Plan design: CEO bonus is a percentage of HCSG’s income before income taxes (IBIT), with a max of 2× salary; no discretion applied to CEO outcome .
  • Wahl elected to take 35% of his annual incentive in stock for 2023 and 2024 .
YearMetricTargetActual PayoutStructurePaid in CashPaid in Stock
2023% of IBIT (CEO formula)Not disclosed40% of salary Annual (no discretion) $258,648 $139,265
2024% of IBIT (CEO formula)Not disclosed40% of salary Annual (no discretion) $258,092 $138,966

Long-Term Incentives (Equity)

  • Vehicle mix: Stock options + RSUs (time-based, vest ratably over 5 years) + PSUs (3-year relative TSR vs S&P MidCap 400) .
  • PSU payout schedule: <25th percentile: 0%; 25th: 50%; 50th: 100%; ≥75th: 150% (interpolated in between) .
Grant YearOptions (#)Option FV ($)RSUs (#)RSU FV ($)PSUs (#)PSU FV ($)Vesting / Terms
2023116,799 762,697 111,190 1,525,527 47,075 762,615 Options/RSUs vest 20%/yr over 5 yrs; PSUs cliff after 3-yr TSR period (to 12/31/2025) .
2024156,735 793,643 153,213 1,587,287 66,974 793,642 Options/RSUs vest 20%/yr over 5 yrs; PSUs cliff after 3-yr TSR period (to 12/31/2026) .

Option exercise price for 2024 grant: $10.36; expiration 1/3/2034 .

Outstanding Equity (selected as of 12/31/2024)

InstrumentGrantExercisableUnexercisableExercise/TermsUnvested RSUs (#)Unvested PSUs (#)
Stock Options1/3/2024156,735$10.36; exp. 1/3/2034
Stock Options2/24/202323,36093,439$13.72; exp. 2/24/2033
RSUs1/3/20245-year ratable vest 153,213
PSUs2024 cycle3-year relative TSR to 12/31/2026 66,974

Note: Additional prior-cycle grants remain outstanding; see full award table for all positions and fair values .

Equity Ownership & Alignment

ItemDetail
Total Beneficial Ownership1,055,671 shares (≈1.4% of shares outstanding) .
Components (footnote)Includes 14,218 ISO and 450,355 NQ options currently exercisable; 38,383 SERP-credited shares (unissued); and 77,958 (spouse) + 39,389 (children) shares .
Ownership GuidelinesCEO required to own ≥600% of salary; Wahl at 838% as of 12/31/2024; retention requirements apply if below threshold .
Hedging/PledgingHedging prohibited under insider trading policy; policy outlines blackout periods; no pledging disclosure noted .

Employment Terms

  • Employment agreement and severance: HCSG discloses no employment agreements for NEOs; severance multiples are not enumerated; equity follows plan terms .
  • Change-in-control: Double-trigger vesting under 2020 Omnibus Plan (unassumed awards vest; if assumed, vest on qualifying termination or for good reason) .
  • Clawback: Nasdaq/SEC-compliant clawback adopted; applies to incentive-based compensation for 3 years prior to an accounting restatement; “no-fault” recovery possible; 2024 review found no recovery required .
  • Insider trading controls: Blackout windows; no hedging/derivatives; trading policy applies to insiders .
  • Pay philosophy: CEO base salary unchanged since 2016; majority of compensation at-risk via annual IBIT-based incentive and multi-year equity mix .

Board Governance

  • Roles and independence: Wahl is a director (since 2011) with no committee assignments; Board is majority independent and chaired by independent director Jude Visconto; Wahl is a management (non-independent) director .
  • Attendance: In 2024, each director attended ≥75% of meetings (Board + committees) .
  • Executive sessions: Independent chair presides over executive sessions without management .
  • Director compensation: Employee directors (including Wahl) receive no additional director fees/equity for board service .

Compensation Structure Analysis

  • Mix and trends: CEO salary level fixed since 2016 while equity and variable pay drive outcomes; 2024 LTI grant increased year over year (higher RSU/option/PSU counts vs 2023), maintaining 5-year RSU/option vesting and 3-year PSU performance cycles .
  • Performance linkage: CEO annual incentive strictly formulaic on IBIT (40% of salary in both 2023 and 2024) with partial stock settlement elected (35%), reinforcing alignment .
  • PSU metric rigor: Relative TSR vs S&P MidCap 400 with threshold/target/max at 25th/50th/75th percentiles (50%/100%/150% payout), creating outcome sensitivity to shareholder returns; 2024 award tied to 2024–2026 window .
  • Governance features: Double-trigger CoC, formal clawback, no tax gross-ups, no special executive-only retirement plans (SERP is broad-based to eligible executives), anti-hedging policy .

Director Compensation, Peer Group, and Say-on-Pay

  • Director Fees (context): Non-employee directors receive cash retainers and DSUs; as an employee, Wahl receives none for director service .
  • Peer Group for benchmarking: ABM Industries, Amedisys, AMN Healthcare, Chemed, Clean Harbors, CoreCivic, J&J Snack Foods, Brink’s, Modivcare, UniFirst (periodically reviewed) .
  • Say-on-Pay: Support of ~91% in 2024 and 93% in 2023, indicating broad shareholder approval of program design .

Related Party Transactions and Other Compliance

  • Related party: Wahl’s brother-in-law, Matthew J. McKee (Chief Communications Officer), total comp ≈$770K in 2024 and ≈$719K in 2023; Audit Committee reviewed and deemed comparable to market .
  • Section 16 reporting: One Form 4 for a phantom stock award (including for Wahl) was filed late in January 2025; otherwise timely compliance for FY2024 per company review .

Performance & Track Record

  • Financial and operating highlights (2024): YOY increases in revenues and net income; >500 new service agreements, >150 client ownership changes, ~90% retention; continuing buybacks ($23M+ since Feb 2023 authorization); ROA 4.9%, ROE 7.9%, ROIC 9.7% .
  • TSR context: Company TSR value of $54 versus peer group $164 on initial $100 (2020–2024), underscoring residual market underperformance despite operational progress; PSU structure directly reflects this dynamic .

Equity Ownership & Outstanding Awards (Detail)

Beneficial Ownership (3/31/2025)Amount
Wahl Shares Beneficially Owned1,055,671 (≈1.4% of 72,916,000 outstanding)
Footnote Components14,218 ISO + 450,355 NQ options exercisable; 38,383 SERP-credited; spouse 77,958; children 39,389
2024 Grants (1/3/2024)# / $
Options Granted (#)156,735
Option Grant Date FV ($)793,643
RSUs Granted (#)153,213
RSU Grant Date FV ($)1,587,287
PSUs Granted (#)66,974
PSU Grant Date FV ($)793,642

Employment Terms (Plan Features Summary)

  • No individual employment contract; equity governed by 2020 Plan; double-trigger CoC; Nasdaq/SEC clawback adopted; anti-hedging; blackout periods; no repricing/backdating; no tax gross-ups .

Investment Implications

  • Alignment positives: Wahl’s high ownership (838% of salary vs 600% guideline), repeated election to take a portion (35%) of annual incentive in stock, and heavier use of multi-year PSUs suggest strong long-term alignment and reduced near-term selling pressure from time-based awards vesting linearly over five years .
  • Governance quality: Double-trigger CoC, clawback, anti-hedging, independent chair, and majority independent board mitigate governance risk; related-party employment is disclosed and reviewed by Audit Committee .
  • Performance risk: TSR underperformance vs peers could dampen PSU realizations and weigh on realized pay, but provides upside leverage if multi-year TSR converges toward medians; IBIT-linked annual incentive maintains operating discipline .
  • Retention/overhang: Significant unvested RSUs/options/PSUs with long vesting and multi-year performance windows support retention; 2024 option strike ($10.36) frames option moneyness sensitivity to share price recovery .